Skip to main content
. 2012 Mar 12;7(3):e33431. doi: 10.1371/journal.pone.0033431

Figure 1. MSI1 expression in glioblastoma cell lines, medulloblastoma cell lines, and low-passage cells from glioblastoma patients.

Figure 1

(A) Immunoblots showing the MSI1 expression in human glioblastoma cell lines (U251MG, and KNS42), low-passage glioblastoma cells obtained from patients GM97, GM1600, GM1605, and a human medulloblastoma cell line (Daoy). (B and C) The selective depletion of MSI1 protein by treatment with shRNAs in U251MG cells (B) and Daoy cells (C). β-actin was used as a loading control in all the experiments.